2013Shijie zhongxiyi jiehe zazhiRequires access

Clinical Obstruction of 32 Cases of Diabetic Peripheral Neuropathy Treated with JianpiRouganTongluo Formula

Ranwei Li

Open publisher page 0 citations

Abstract

Objective To observe the clinical efficacy on diabetic peripheral neuropathy(DPN) treated with JianpiRouganTongluo Formula.Methods Seventy cases were randomized into a treatment group(35 cases,3 of them were dropped);and a control group(35 cases,4 of them were dropped).In the treatment group,JianpiRouganTongluoDecoction was applied,one dose a day.In the control group,Cobamamide was used for acupoint injection,three times a week.The duration of treatment was 28 days in the two groups.The results of NSS,MDNS,QQL-BREF and clinical efficacy were observed and compared between the two groups.Results The scores of NSS and MDNS were all improved in the treatment group and the controlgroup.The survival quality of patients was improved obviously and the difference was significant before and after treatment(P 0.05).The group comparison indicated that the result in the treatment group was better than that in the control group(P 0.05).The total effective rate in the treatment group was higher than that in the control group.Conclusion JianpiRouganTongluo Formula achieves the definite efficacy on DPN.It relieves greatly the clinical symptoms and physical signs and improves the survival quality of patients.

About this research paper

What this paper is about

Objective To observe the clinical efficacy on diabetic peripheral neuropathy(DPN) treated with JianpiRouganTongluo Formula.Methods Seventy cases were randomized into a treatment group(35 cases,3 of them were dropped);and a control group(35 cases,4 of them were dropped).In the treatment group,JianpiRouganTongluoDecoction was applied,one dose a day.In the control group,Cobamamide was used for acupoint injection,three times a week.The duration of treatment was 28 days in the two groups.The results of NSS,MDNS,QQL-BREF and clinical efficacy were observed and compared between the two groups.Results The scores of NSS and MDNS were all improved in the treatment group and the controlgroup.The survival quality of patients was improved obviously and the difference was significant before and after treatment(P 0.05).The group comparison indicated that the result in the treatment group was better than that in the control group(P 0.05).The total effective rate in the treatment group was higher than that in the control group.Conclusion JianpiRouganTongluo Formula achieves the definite efficacy on DPN.It relieves greatly the clinical symptoms and physical signs and improves the survival quality of patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacy on diabetic peripheral neuropathy(DPN) treated with JianpiRouganTongluo Formula.Methods Seventy cases were randomized into a treatment group(35 cases,3 of them were dropped);and a control group(35 cases,4 of them were dropped).In the treatment group,JianpiRouganTongluoDecoction was applied,one dose a day.In the control group,Cobamamide was used for acupoint injection,three times a week.The duration of treatment was 28 days in the two groups.The results of NSS,MDNS,QQL-BREF and clinical efficacy were observed and compared between the two groups.Results The scores of NSS and MDNS were all improved in the treatment group and the controlgroup.The survival quality of patients was improved obviously and the difference was significant before and after treatment(P 0.05).The group comparison indicated that the result in the treatment group was better than that in the control group(P 0.05).The total effective rate in the treatment group was higher than that in the control group.Conclusion JianpiRouganTongluo Formula achieves the definite efficacy on DPN.It relieves greatly the clinical symptoms and physical signs and improves the survival quality of patients.

Key concepts: Medicine, Peripheral neuropathy, Clinical efficacy, Treatment and control groups, Surgery, Clinical trial, Internal medicine, Anesthesia

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Obstruction of 32 Cases of Diabetic Peripheral Neuropathy Treated with JianpiRouganTongluo Formula — Research Paper | ScholarLens